{
  "id": "28bb984321519958",
  "title": "STAT+: Investor behind Moderna says U.S. policy is \u2018taking a sledgehammer to our miracle machine\u2019",
  "description": "Noubar Afeyan, one of biotech\u2019s top investors, says U.S. policy is \"taking a sledgehammer to our miracle machine.\"",
  "content": "Noubar Afeyan, one of biotech\u2019s top investors, says U.S. policy is \"taking a sledgehammer to our miracle machine.\"",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/12/noubar-afeyan-letter-investors-jpm-2026/?utm_campaign=rss",
  "published_at": "2026-01-12T10:00:00+00:00",
  "fetched_at": "2026-01-13T00:20:01.657666+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: Investor behind Moderna says U.S. policy is \u2018taking a sledgehammer to our miracle machine\u2019",
    "description": "Noubar Afeyan, one of biotech\u2019s top investors, says U.S. policy is \"taking a sledgehammer to our miracle machine.\"",
    "url": "https://www.statnews.com/2026/01/12/noubar-afeyan-letter-investors-jpm-2026/?utm_campaign=rss",
    "published": "2026-01-12T10:00:00+00:00",
    "source": "STAT"
  }
}